Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beijing Sunho Pharmaceutical CoBJSE:920017 80 Days Inventory is 121.32 as of Jun. 2026, which is 4% above its 10-year median of 116.46. GuruFocus rates BJSE:920017 with a GF Score™ of 80/100 and a GF Value™ of ¥15.19 (Fairly Valued). The stock has 2 warning signs investors should review. Among 921 Drug Manufacturers companies, Beijing Sunho Pharmaceutical Co ranks better than 64.5% on this metric.
The historical rank and industry rank for Beijing Sunho Pharmaceutical Co's Days Inventory or its related term are showing as below:
BJSE:920017'
s Days Inventory Range Over the Past 10 Years
Min: 102.52 Med: 116.46 Max: 129.74
Current: 129.6
During the past 10 years, Beijing Sunho Pharmaceutical Co's highest Days Inventory was 129.74. The lowest was 102.52. And the median was 116.46.
BJSE:920017's Days Inventory is ranked better than 64.5% of 921
companies
in the Drug Manufacturers industry
Industry Median: 165.34
vs BJSE:920017: 129.60
Inventory Turnover measures how fast the company turns over its inventory within a year.
Beijing Sunho Pharmaceutical Co's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.75.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Beijing Sunho Pharmaceutical Co's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.47.
Beijing Sunho Pharmaceutical Co (BJSE:920017) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Beijing Sunho Pharmaceutical Co's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Beijing Sunho Pharmaceutical Co's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Beijing Sunho Pharmaceutical Co Days Inventory Related Terms
Beijing Sunho Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Sunho Pharmaceutical Co Days Inventory Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Sunho Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Sunho Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beijing Sunho Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Beijing Sunho Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Sunho Pharmaceutical Co (BJSE:920017) has a Days Inventory of 121.32 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Beijing Sunho Pharmaceutical Co and its competitors. This is near median its historical median of 116.46. Over the past decade, Beijing Sunho Pharmaceutical Co's Days Inventory has ranged from 102.52 to 129.74. According to the industry distribution chart, Beijing Sunho Pharmaceutical Co ranks #327 out of 921 companies in the Drug Manufacturers industry, placing it in the top 35.5%.
Is Beijing Sunho Pharmaceutical Co's Days Inventory too high?
Beijing Sunho Pharmaceutical Co's current Days Inventory of 121.32 is near median its 10-year median of 116.46. Over the past 10 years, this metric has ranged from a low of 102.52 to a high of 129.74. The Drug Manufacturers industry median Days Inventory is 165.34. Beijing Sunho Pharmaceutical Co's value of 121.32 is 26.6% below this industry median. Based on the distribution chart, Beijing Sunho Pharmaceutical Co ranks #327 out of 921 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Beijing Sunho Pharmaceutical Co has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Beijing Sunho Pharmaceutical Co's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Beijing Sunho Pharmaceutical Co ranks #327 out of 921 companies for Days Inventory. This puts Beijing Sunho Pharmaceutical Co in the upper half of its industry. The industry median Days Inventory is 165.34. Beijing Sunho Pharmaceutical Co's value of 121.32 is 26.6% below this benchmark. Historically, Beijing Sunho Pharmaceutical Co's own Days Inventory has ranged from 102.52 to 129.74 over the past decade. While the company's 10-year median is 116.46 vs. the industry median of 165.34, Beijing Sunho Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.34, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Sunho Pharmaceutical Co's current Days Inventory of 121.32 is 26.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Beijing Sunho Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Sunho Pharmaceutical Co's current Days Inventory is 121.32, which is near median its own 10-year median of 116.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Sunho Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Sunho Pharmaceutical Co (BJSE:920017) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.19, compared to a current price of ¥15.67 — trading 3.2% above its estimated fair value. The current Days Inventory is 121.32, which is near median its 10-year median of 116.46 and 26.6% below the Drug Manufacturers industry median of 165.34. Beijing Sunho Pharmaceutical Co's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Beijing Sunho Pharmaceutical Co (BJSE:920017), the current Days Inventory is 121.32 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Sunho Pharmaceutical Co (BJSE:920017) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Sunho Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥15.67 is trading 3.2% above its estimated GF Value™ of ¥15.19.
GuruFocus considers Beijing Sunho Pharmaceutical Co to be Fairly Valued.
Key valuation signals for BJSE:920017:
Days Inventory: 121.32 (near median its 10-year median of 116.46)
GF Value™: ¥15.19 vs. price of ¥15.67 (3.2% above fair value)
Industry Position: 26.6% below the Drug Manufacturers median (#327 of 921)
No single metric tells the full story. See the BJSE:920017 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Sunho Pharmaceutical Co Ltd engages in the research and development, production, and sales of pharmaceutical preparations while providing CMC/CMO integrated services for pharmaceutical preparation manufacturers and drug R&D enterprises. The company produces small-volume injections, freeze-dried powder injections, hard capsules, tablets, and other products. The company's main products included: compound digestive enzyme capsules, piracetam (small injection and powder injection), and oxalic acid acetate.
80GF Score
Get the complete analysis for BJSE:920017
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920017 has been successfully added to your 
